PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant Chemotherapy
Open Access
- 16 December 2007
- journal article
- case report
- Published by Hindawi Limited in Sarcoma
- Vol. 2007, 1-3
- https://doi.org/10.1155/2007/53056
Abstract
Purpose: Tumors of the perivascular epithelial cell tumor (PEComa), first described in 1992, represent a rare soft tissue neoplasm of varying malignant potential. Cases of PEComa have been previously described in a few somatic and visceral sites, most notably in the gastrointestinal tract, genitourinary tract, and one extremity case in the thigh. To date, most malignant cases of PEComa have been resistant to chemotherapy, and as such, an appropriate therapy is not known. Case report: Here we describe the first case of PEComa of the upper extremity. Open biopsy revealed a high-grade malignant lesion, and the patient subsequently underwent both neoadjuvant therapy with doxorubicin, ifosfamide and mensa, and radiation therapy prior to wide surgical resection. After six cycles of chemotherapy, the tumor underwent an 80% reduction in size. Subsequent neoadjuvant radiation therapy of 5000 cGy did not further reduce the size of the tumor. Following limb sparing radical resection, pathology showed 20% necrosis within a high-grade malignant lesion. Twenty one months after beginning treatment, the patient shows no sign of local recurrence, but metastatic disease was confirmed after resection of a lung nodule. Conclusion: Given the favorable albeit partial response seen in this patient, the course of therapy outlined here may represent a good starting point for neoadjuvant treatment in a tumor with a historically bleak prognosis. In addition, the diagnosis of PEComa must now be entertained in the differential diagnosis of upper extremity soft tissue sarcoma.Keywords
This publication has 20 references indexed in Scilit:
- Lack of response of a metastatic renal perivascular epithelial cell tumor (PEComa) to successive courses of DTIC based-therapy and imatinib mesylatePediatric Blood & Cancer, 2005
- Neoadjuvant and Adjuvant Therapy for Extremity Soft Tissue SarcomasHematology/Oncology Clinics of North America, 2005
- Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcomaAnnals of Oncology, 2004
- Down syndrome and leukemia: New insights into the epidemiology, pathogenesis, and treatmentPediatric Blood & Cancer, 2004
- Clear Cell Myomelanocytic Tumor of the ThighThe American Journal of Surgical Pathology, 2002
- Abdominopelvic Sarcoma of Perivascular Epithelioid Cells. Report of Four Cases in Young Women, One with Tuberous SclerosisLaboratory Investigation, 2001
- Malignant Epithelioid Angiomyolipoma (`Sarcoma Ex Angiomyolipoma') of the KidneyThe American Journal of Surgical Pathology, 2001
- Clear Cell Myomelanocytic Tumor of the Falciform Ligament/Ligamentum TeresThe American Journal of Surgical Pathology, 2000
- Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual dataThe Lancet, 1997
- Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma— The concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC)Pathology, 1994